A new method Development and Validation of Agomelatine by RP-HPLC in its bulk and tablet dosage form

A new method Development and Validation of Agomelatine by RP-HPLC in its bulk and tablet dosage form
Author(s):
Gangu Sreelatha, Thummanapalli Priyanka, K. Ratna Jyothi
Keywords:
Agomelatine, Antagonist, Chromatography, Buffer, Depressive Disorder.
Abstract
A novel and simple Reverse phase liquid chromatographic method was established for the determination of Agomelatine in presence of degradants. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. It is used for the treatment of major depressive disorder. The proposed work was performed on Thermo Hypersil extended C18 column (250 mm × 4.6 mm i.e., 5 µm particle size) using a mixture of Buffer (4.3pH) and methanol (60:40) as mobile phase with flow rate 1.0 ml/min. Water and Methanol (50:50) was used as diluent. The retention time was found to be 3.374 min. The linearity range used was 25-75µg/ml. The %RSD was found to be less than 2%. LOD & LOQ values were found to be 3.3002 and 10.0008µg/ml respectively.
Article Details
Unique Paper ID: 161180 Publication Volume & Issue: Volume 10, Issue 2 Page(s): 857 - 863
Article Preview & Download

Share This Article

NCSST-2023

AICTE Sponsored National Conference on Smart Systems and Technologies

Last Date: 25th November 2023

LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT

Last Date: 7th November 2023

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org